Lakshmi Ganapathi, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance Abuse, Intravenous | 5 | 2024 | 530 | 2.450 |
Why?
|
Harm Reduction | 2 | 2024 | 143 | 1.020 |
Why?
|
Splenomegaly | 1 | 2024 | 192 | 0.880 |
Why?
|
Common Variable Immunodeficiency | 1 | 2024 | 99 | 0.860 |
Why?
|
Family Therapy | 1 | 2024 | 214 | 0.830 |
Why?
|
Drug Users | 1 | 2023 | 134 | 0.750 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2024 | 951 | 0.610 |
Why?
|
Fever | 1 | 2024 | 1613 | 0.540 |
Why?
|
HIV Infections | 5 | 2024 | 17569 | 0.530 |
Why?
|
Schistosoma haematobium | 1 | 2015 | 14 | 0.510 |
Why?
|
Transplantation | 1 | 2017 | 221 | 0.510 |
Why?
|
Schistosomiasis haematobia | 1 | 2015 | 16 | 0.510 |
Why?
|
Liver Diseases | 1 | 2024 | 1305 | 0.500 |
Why?
|
Buprenorphine | 1 | 2023 | 667 | 0.480 |
Why?
|
Toll-Like Receptor 8 | 1 | 2015 | 98 | 0.470 |
Why?
|
Tuberculosis, Pleural | 1 | 2014 | 14 | 0.460 |
Why?
|
Ethics, Medical | 1 | 2019 | 785 | 0.460 |
Why?
|
Toll-Like Receptor 7 | 1 | 2015 | 169 | 0.450 |
Why?
|
Hematuria | 1 | 2015 | 232 | 0.450 |
Why?
|
Urine | 1 | 2015 | 362 | 0.450 |
Why?
|
Developing Countries | 2 | 2024 | 2913 | 0.430 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1086 | 0.430 |
Why?
|
Cytomegalovirus Infections | 1 | 2019 | 836 | 0.420 |
Why?
|
Physician's Role | 1 | 2019 | 925 | 0.410 |
Why?
|
India | 4 | 2024 | 2334 | 0.400 |
Why?
|
Quinolines | 1 | 2015 | 770 | 0.340 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1406 | 0.330 |
Why?
|
Imidazoles | 1 | 2015 | 1168 | 0.320 |
Why?
|
Organ Transplantation | 1 | 2019 | 1176 | 0.320 |
Why?
|
Liver | 1 | 2024 | 7574 | 0.310 |
Why?
|
Substance-Related Disorders | 1 | 2024 | 4423 | 0.290 |
Why?
|
Leukocytes | 1 | 2015 | 2035 | 0.280 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3740 | 0.270 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5520 | 0.260 |
Why?
|
Relapsing Fever | 1 | 2024 | 25 | 0.230 |
Why?
|
Cytokines | 2 | 2016 | 7450 | 0.220 |
Why?
|
Digestive System Diseases | 1 | 2024 | 152 | 0.210 |
Why?
|
Education, Medical, Graduate | 1 | 2014 | 2420 | 0.200 |
Why?
|
Granuloma | 1 | 2024 | 329 | 0.200 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2024 | 174 | 0.190 |
Why?
|
Needle Sharing | 1 | 2019 | 22 | 0.160 |
Why?
|
Pediatrics | 1 | 2014 | 3629 | 0.160 |
Why?
|
Adolescent | 8 | 2024 | 89155 | 0.150 |
Why?
|
Unsafe Sex | 1 | 2019 | 239 | 0.140 |
Why?
|
Emigration and Immigration | 1 | 2019 | 406 | 0.130 |
Why?
|
Homosexuality, Male | 1 | 2024 | 1344 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2024 | 1397 | 0.130 |
Why?
|
Public Policy | 1 | 2019 | 552 | 0.120 |
Why?
|
Eritrea | 1 | 2014 | 4 | 0.120 |
Why?
|
Cytomegalovirus | 1 | 2019 | 751 | 0.120 |
Why?
|
Laos | 1 | 2014 | 27 | 0.120 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2016 | 705 | 0.120 |
Why?
|
Child | 8 | 2023 | 80906 | 0.120 |
Why?
|
Steroids | 1 | 2019 | 938 | 0.110 |
Why?
|
Cambodia | 1 | 2014 | 185 | 0.110 |
Why?
|
Internship and Residency | 1 | 2014 | 5952 | 0.110 |
Why?
|
Training Support | 1 | 2014 | 109 | 0.110 |
Why?
|
Bone Marrow | 1 | 2024 | 2935 | 0.110 |
Why?
|
Humans | 19 | 2024 | 767991 | 0.110 |
Why?
|
Risk-Taking | 1 | 2019 | 1023 | 0.110 |
Why?
|
DNA, Viral | 1 | 2019 | 2201 | 0.100 |
Why?
|
Toll-Like Receptors | 1 | 2016 | 582 | 0.100 |
Why?
|
Poverty | 1 | 2024 | 2720 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8507 | 0.100 |
Why?
|
Kenya | 1 | 2014 | 757 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5717 | 0.090 |
Why?
|
Male | 10 | 2024 | 364641 | 0.090 |
Why?
|
Th1 Cells | 1 | 2016 | 1042 | 0.090 |
Why?
|
Adjuvants, Immunologic | 1 | 2016 | 998 | 0.090 |
Why?
|
Th2 Cells | 1 | 2016 | 1076 | 0.090 |
Why?
|
Salmonella typhi | 1 | 2012 | 200 | 0.090 |
Why?
|
Typhoid Fever | 1 | 2012 | 195 | 0.090 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7470 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1942 | 0.080 |
Why?
|
Sexual Behavior | 1 | 2019 | 2197 | 0.080 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 13000 | 0.080 |
Why?
|
Fetal Blood | 1 | 2015 | 1361 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6211 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4362 | 0.080 |
Why?
|
Young Adult | 4 | 2024 | 60048 | 0.070 |
Why?
|
International Cooperation | 1 | 2014 | 1434 | 0.070 |
Why?
|
Risk | 1 | 2019 | 9609 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1321 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13665 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2019 | 3073 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 3837 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20757 | 0.070 |
Why?
|
Boston | 1 | 2019 | 9368 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4146 | 0.070 |
Why?
|
HEK293 Cells | 1 | 2015 | 4289 | 0.060 |
Why?
|
Parents | 1 | 2019 | 3595 | 0.060 |
Why?
|
Female | 7 | 2024 | 397113 | 0.060 |
Why?
|
Diarrhea | 1 | 2012 | 1320 | 0.060 |
Why?
|
Incidence | 2 | 2024 | 21532 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6071 | 0.060 |
Why?
|
Adult | 6 | 2024 | 223583 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2015 | 2745 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3782 | 0.060 |
Why?
|
Qualitative Research | 1 | 2014 | 3140 | 0.050 |
Why?
|
Brain Diseases | 1 | 2012 | 1554 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 1 | 2014 | 1930 | 0.050 |
Why?
|
Logistic Models | 2 | 2014 | 13289 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4205 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18407 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15867 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4857 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8748 | 0.050 |
Why?
|
United States | 2 | 2019 | 73027 | 0.040 |
Why?
|
Infant | 2 | 2019 | 36534 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2023 | 81746 | 0.040 |
Why?
|
Vancomycin | 1 | 2021 | 504 | 0.040 |
Why?
|
Child, Preschool | 2 | 2019 | 42665 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2016 | 26420 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26375 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8744 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36742 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2023 | 1874 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 30260 | 0.030 |
Why?
|
Serotyping | 1 | 2012 | 331 | 0.020 |
Why?
|
Aged | 1 | 2024 | 171446 | 0.020 |
Why?
|
Bangladesh | 1 | 2012 | 742 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14783 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9252 | 0.020 |
Why?
|
Bacteremia | 1 | 2012 | 986 | 0.020 |
Why?
|
Animals | 1 | 2015 | 169222 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10840 | 0.010 |
Why?
|
Hospitals | 1 | 2012 | 3886 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 223422 | 0.010 |
Why?
|